March 19, 2018 / 5:09 PM / 5 months ago

BRIEF-Sygnis To Raise Capital To Buy TGR Biosciences

March 19 (Reuters) - SYGNIS AG:

* SYGNIS AG TO RAISE CAPITAL VIA A PRIVATE PLACEMENT OF NEW SHARES TO ACQUIRE TGR BIOSCIENCES

* TO LAUNCH A PRIVATE PLACEMENT OF UP TO 4.7 MILLION NEW SHARES TO INSTITUTIONAL INVESTORS IN EUROPE

* PRICE PER SHARE IS SET TO EUR 1.40

* PLANS TO USE PROCEEDS FROM TRANSACTION FOR ACQUISITION OF AUSTRALIAN RESEARCH REAGENTS COMPANY TGR BIOSCIENCES

* ACQUISITION OF TGR BIOSCIENCES WAS PRICED AT A VALUE OF EUR 10.4 MILLION

* REACHED AGREEMENT WITH CURRENT MAJORITY SHAREHOLDERS OF TARGET COMPANY, REPRESENTING 78 PCT OF TOTAL VOTING RIGHTS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below